Rheumatology NewsPrior biologic exposure doesn’t diminish ixekizumab’s efficacyJanuary 8, 2018Psoriatic Arthritis
Rheumatology NewsFDA approves tofacitinib for psoriatic arthritisDecember 15, 2017Psoriatic Arthritis
Rheumatology NewsGuselkumab crushes skin disease in psoriatic arthritis patientsDecember 15, 2017Psoriatic Arthritis
Rheumatology NewsFDA approves infliximab biosimilar Ixifi for all of Remicade’s indicationsDecember 14, 2017Rheumatoid ArthritisPsoriatic ArthritisSpondyloarthropathiesAnkylosing spondylitis
Rheumatology NewsTesting for latent tuberculosis infectionDecember 13, 2017SpondyloarthropathiesRheumatoid ArthritisPsoriatic ArthritisAnkylosing spondylitisLupus & Connective Tissue Diseases
Rheumatology NewsInterleukin-23 inhibition for psoriasis shows ‘wow’ factorDecember 11, 2017Psoriatic Arthritis
Rheumatology NewsArthritis prevalence higher than previously thought, especially in adults under 65December 5, 2017OsteoarthritisRheumatoid ArthritisPsoriatic Arthritis
Rheumatology NewsFDA approves IL-17A antagonist for treating psoriatic arthritisDecember 2, 2017Psoriatic Arthritis
Rheumatology NewsExpert discusses risks of biosimilars in rheumatologyNovember 30, 2017Psoriatic ArthritisRheumatoid ArthritisSpondyloarthropathiesAnkylosing spondylitis
Rheumatology NewsTopical tapinarof heads for phase 3 in atopic dermatitis and psoriasisNovember 11, 2017Psoriatic Arthritis
Rheumatology NewsUstekinumab may reduce risk of nonmelanoma skin cancerNovember 7, 2017Psoriatic Arthritis
Rheumatology NewsModerate psoriasis: the new frontier for systemic therapiesNovember 6, 2017Psoriatic Arthritis
Rheumatology NewsPsA disease activity instruments differ on residual diseaseNovember 3, 2017Psoriatic Arthritis
Rheumatology NewsGuselkumab tops adalimumab for psychiatric comorbidities in psoriasisOctober 31, 2017Psoriatic Arthritis
